Skip to main content
Premium Trial:

Request an Annual Quote

staff reporter

Articles Authored by staff reporter

Dec 2, 2022

In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences

Dec 2, 2022

Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy

Dec 2, 2022

FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML

Dec 1, 2022

Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers

Dec 1, 2022

Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer

Dec 1, 2022

Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round

Nov 30, 2022

Addario Lung Cancer Medical Institute Begins Study Exploring KRAS Inhibitor Resistance

Nov 30, 2022

Erasca Inks Deal With Pierre Fabre on ERAS-007, Braftovi Combo Study in Colorectal Cancer

Nov 30, 2022

Theralink Technologies to Raise $3.1M in Private Placements

Nov 30, 2022

Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring